Nordic Nanovector is committed to developing and delivering innovative therapies to patients to address major unmet medical needs. The Company aspires to become a leader in the development of CD37-targeted therapies for hematological cancers and immune diseases.

Biotechnology

Nordic Nanovector

Nordic Nanovector's headquarters in Oslo, Norway

Ludvik Sandnes

Stein Rune Kjelby

margrethe Sørgaard

Lars Nieba

Jostein Dahle

Timothy Illidge

Mark Kaminski

Lorenz Trümper

Wojciech Jurczak

Pier Luigi Zinzani

Stephen Schuster

Francesco D'Amore

Tina Bjørnlund Bønsdorff

Arne Kolstad

Jon Magne Asmyr

Description

People (2)

Theo S. Dogbeten

Stein Rune Kjelby

Jobs